Hologic Says FDA Approves Aptima HPV Assay For Use On Panther System

(RTTNews) - Hologic Inc. (HOLX), Tuesday said the U.S. Food and Drug Administration has approved its Aptima HPV assay for use on the company's fully-automated Panther system.

The Aptima HPV test is performed with Hologic's ThinPrep liquid cytology specimen and can be tested before and after it has been processed for cytology testing on the ThinPrep 2000 system.

Hologic's Aptima HPV mRNA based assay is a nucleic acid amplified test that detects 14 high-risk strains of human papillomavirus (HPV) associated with cervical cancer and precancerous lesions, and has demonstrated significantly improved specificity with no compromise in disease detection.